AC
AUXL

Ascend Capital’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Ascend Capital’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-388,549
Closed -$6.46M – 260
2013
Q2 		$6.46M Buy
+388,549
New +$6.21M 0.27% 105

Other funds holding AUXL

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ascend Capital's AUXL Position: Q3 2013 in Review

Ascend Capital sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q3 2013, closing a stake of 388,549 shares — an estimated $6.46M sold.

Ascend Capital first reported a position in AUXL in Q2 2013 and held it in 1 quarter. The position peaked at $6.46M in Q2 2013. 150 funds tracked by Wall St. Rank hold AUXL as of Q3 2013.

  • Ascend Capital reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • Ascend Capital sold 388,549 AUXILIUM PHARAMCEUTICALS INC shares in Q3 2013, an estimated $6.46M.
  • Ascend Capital first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • Ascend Capital's AUXILIUM PHARAMCEUTICALS INC position peaked at $6.46M in Q2 2013.
  • 150 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q3 2013.

Based on Ascend Capital's 13F filing for Q3 2013, filed 13 Nov 2013.